➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Medtronic
Mallinckrodt
McKinsey
Harvard Business School

Last Updated: October 23, 2020

DrugPatentWatch Database Preview

Claims for Patent: 10,022,445

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,022,445
Title:Patch
Abstract: In a patch comprising a support layer and an adhesive agent layer, the adhesive agent layer comprises free asenapine, a maleic acid alkali salt, and a rubber-based adhesive agent.
Inventor(s): Sonobe; Atsushi (Tsukuba, JP), Yasukochi; Takashi (Tsukuba, JP), Takada; Yasunori (Tsukuba, JP)
Assignee: HISAMITSU PHARMACEUTICAL CO., INC. (Tosu-shi, JP)
Application Number:14/416,983
Patent Claims: 1. A patch, comprising: a support layer; and an adhesive agent layer formed on the support layer, wherein the adhesive agent layer comprises free asenapine, a maleic acid alkali salt, and a rubber-based adhesive agent, the free asenapine and the maleic acid alkali salt are generated from an asenapine maleic acid salt and an alkali metal ion-containing desalting agent, the alkali metal ion-containing desalting agent is at least one of a metal hydroxide and an acetic acid metal salt and is in an amount of 0.5 to 6 equivalents to the asenapine maleic acid salt in terms of acid-base equivalence, the rubber-based adhesive agent has a content in a range of 10% by mass to 50% by mass in the adhesive agent layer and is at least one selected from the group consisting of a styrene-isoprene-styrene block copolymer, polyisobutylene, and a silicone rubber, and the maleic acid alkali salt has a content in a range of 0.5% by mass to 15% by mass in the adhesive agent layer.

2. The patch according to claim 1, wherein the adhesive agent layer comprises at least one absorption enhancer selected from the group consisting of isostearyl alcohol, capric acid, propylene glycol monolaurate, isopropyl myristate, isopropyl palmitate, laurie acid diethanolamide, propylene glycol, and polyethylene glycol.

3. The patch according to claim 1, wherein the alkali metal ion-containing desalting agent is in an amount of 0.75 to 4 equivalents to the asenapine maleic acid salt in terms of acid-base equivalence.

4. The patch according to claim 1, wherein the maleic acid alkali salt is at least one of disodium maleate and monosodium maleate.

5. The patch according to claim 1, wherein the content of the rubber-based adhesive agent in the adhesive agent layer is in a range of 12% by mass to 40% by mass.

6. The patch according to claim 2, wherein the maleic acid alkali salt is at least one of disodium maleate and monosodium maleate.

7. The patch according to claim 3, wherein the maleic acid alkali salt is at least one of disodium maleate and monosodium maleate.

8. The patch according to claim 1, wherein the adhesive agent layer comprises at least one absorption enhancer selected from the group consisting of propylene glycol monolaurate and isopropyl palmitate.

9. The patch according to claim 5, wherein the maleic acid alkali salt is at least one of disodium maleate and monosodium maleate.

10. The patch according to claim 8, wherein the maleic acid alkali salt is at least one of disodium maleate and monosodium maleate.

11. The patch according to claim 2, wherein a content of the rubber-based adhesive agent in the adhesive agent layer is in a range of 12% by mass to 40% by mass.

12. The patch according to claim 1, wherein the alkali metal ion-containing desalting agent is a metal hydroxide.

13. The patch according to claim 1, wherein the alkali metal ion-containing desalting agent is an acetic acid metal salt.

14. The patch according to claim 2, wherein the alkali metal ion-containing desalting agent is a metal hydroxide.

15. The patch according to claim 2, wherein the alkali metal ion-containing desalting agent is an acetic acid metal salt.

16. The patch according to claim 3, wherein the alkali metal ion-containing desalting agent is a metal hydroxide.

17. The patch according to claim 3, wherein the alkali metal ion-containing desalting agent is an acetic acid metal salt.

18. The patch according to claim 4, wherein the alkali metal ion-containing desalting agent is a metal hydroxide.

19. The patch according to claim 4, wherein the alkali metal ion-containing desalting agent is an acetic acid metal salt.

20. The patch according to claim 5, wherein the alkali metal ion-containing desalting agent is one of a metal hydroxide and an acetic acid metal salt.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Express Scripts
Harvard Business School
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.